Skip to main content

Spontaneous malignant transformation of conventional giant cell tumor

Abstract

Spontaneous malignant transformation of conventional giant cell tumor (GCT) of bone is exceedingly rare. We report on a case of GCT of the iliac crest in a 35-year-old woman with malignant change into a high-grade osteosarcoma 10 years after the first appearance of GCT on a radiograph. Since the patient refused therapy for personal reasons the tumor remained untreated until sarcomatous transformation occurred. Image cytometry showed DNA aneuploidy and a suspiciously high 2c deviation index (2cDI) in the primary bone lesion. A thorough review of the world literature revealed only seven fully documented cases of secondary malignant GCT which matched the definition of a “sarcomatous growth that occurs at the site of a previously documented benign giant cell tumor” and not treated by radiotherapy. These cases as well as the current one suggest that a spontaneous secondary malignant GCT presents as a frankly sarcomatous tumor in the form of an osteosarcoma or malignant fibrous histiocytoma. It usually appears at sites of typical GCTs—often without any recurrent intermediate state—and is diagnosed 3 or more years after the primary bone lesion. The prognosis is poor.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

References

  1. Hutter RVP, Worcester JN Jr, Francis KC, Foote FW Jr, Stewart FW. Benign and malignant giant cell tumors of bone: a clinicopathological analysis of the natural history of the disease. Cancer 1962; 15:653–690.

    CAS  Google Scholar 

  2. Dahlin DC, Cupps RE, Johnson EW Jr. Giant-cell tumor: a study of 195 cases. Cancer 1970; 25:1061–1070.

    CAS  PubMed  Google Scholar 

  3. Rock MG, Sim FH, Unni KK, et al. Secondary malignant giant cell tumour of bone: clinicopathological assessment of nineteen patients. J Bone Joint Surg Am 1986; 68:1073–1079.

    Google Scholar 

  4. Fuchs N, Bielack SS, Epler D, et al. Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group’s protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol 1998; 9:893–899.

    CAS  Google Scholar 

  5. Böcking A. DNA measurements. When and why? In: Wied GL, Bartels PH, Rosenthal DL, Schenk V, eds. Compendium on quality assurance, proficiency testing and workload limitations in clinical cytology. Chicago: Tutorials of Cytology, 1995:170–188.

  6. Pomjanski N, Motherby H, Buckstegge B, Knops K, Rohn BL, Böcking A. Early diagnosis of mesothelioma in serous effusions using AgNOR analysis. Anal Quant Cytol Histol 2001; 23:151–159.

    CAS  PubMed  Google Scholar 

  7. Haroske G, Baak JPA, Danielsen H, et al. Fourth updated ESACP consensus report on diagnostic DNA image cytometry. Anal Cell Pathol 2001; 23:89–95.

    CAS  PubMed  Google Scholar 

  8. Werner M, Heintz A, Delling G. DNA cytometry of solitary and aneurysmal bone cysts and low malignancy and high malignancy central osteosarcomas. Current significance within the scope of morphologic diagnosis of intraosseous cystic and osteoblastic lesions. Pathologe 1996; 17:44–49.

    Article  CAS  PubMed  Google Scholar 

  9. Böcking A, Adler CP, Common HH, Hilgarth M, Granzen B, Auffermann. Algorithm for a DNA-cytometric diagnosis and grading of malignancy. Anal Quant Cytol Histol 1984; 6:1-8.

    Google Scholar 

  10. Murphy WR, Ackerman LV. Benign and malignant giant-cell tumors of bone: a clinical-pathological evaluation of thirty-one cases. Cancer 1956; 9:317–339.

    PubMed  Google Scholar 

  11. Sanerkin NG. Malignancy, aggressiveness, and recurrence in giant cell tumor of bone. Cancer 1980; 46:1641–1649.

    CAS  PubMed  Google Scholar 

  12. Schajowicz F. Tumors and tumorlike lesions of bone and joints. Berlin Heidelberg New York: Springer, 1981:232–233.

  13. Boriani S, Sudanese A, Baldini N, Picci P. Sarcomatous degeneration of giant cell tumours. Ital J Orthop Traumatol 1986; 12:191–199.

    CAS  PubMed  Google Scholar 

  14. Venturi R. Osteosarcoma del femore insorto su antico tumore giganto-cellulare. Chir Organi Mov 1986; 71:411–415.

    CAS  PubMed  Google Scholar 

  15. Gitelis S, Wang JW, Quast M, Schajowicz F, Templeton A. Recurrence of a giant-cell tumor with malignant transformation to a fibrosarcoma twenty-five years after primary treatment: a case report. J Bone Joint Surg Am 1989; 71:757–761.

    CAS  PubMed  Google Scholar 

  16. Mori Y, Tsuchiya H, Karita M, Nonomura A, Nojima T, Tomita K. Malignant transformation of a giant cell tumor 25 years after initial treatment. Clin Orthop 2000; 381:185–191.

    PubMed  Google Scholar 

  17. Bertoni F, Bacchini P, Staals EL. Malignancy in giant cell tumor. Skeletal Radiol 2003; 32:143–146.

    CAS  PubMed  Google Scholar 

  18. Mirra JM. Bone tumors. Philadelphia: Lea & Febiger, 1989:993–1020.

  19. Sundaram M, Martin AS, Tayob AA. Case report 182. Spontaneous development of malignancy in a surgically treated giant cell tumor of bone. Skeletal Radiol 1982; 7:282–285.

    CAS  PubMed  Google Scholar 

  20. Hefti FL, Gächter A, Remagen W, Nidecker A. Recurrent giant-cell tumor with metaplasia and malignant change, not associated with radiotherapy. A case report. J Bone Joint Surg Am 1992; 74:930–934.

    Google Scholar 

  21. Ortiz-Cruz EJ, Quinn RH, Fanburg JC, Rosenberg AE, Mankin HJ. Late development of a malignant fibrous histiocytoma at the site of a giant cell tumor. Clin Orthop 1995; 318:199–204.

    PubMed  Google Scholar 

  22. Sakkers RJ, van der Heul RO, Kroon HM, Taminiau AHM, Hogendoorn PCW. Late malignant transformation of a benign giant-cell tumor of bone. A case report. J Bone Joint Surg Am 1997; 79:259–262.

    Google Scholar 

  23. Antal I, Sápi Z, Szendrôi M. Die maligne Entartung eines Riesenzelltumors am distalen Radiusende—Wertigkeit der DNS-Zytophotometrie. Orthopäde 2000; 29:677–683.

    Google Scholar 

  24. Marui T, Yamamoto T, Yoshihara H, Kurosaka M, Mizuno K, Akamatsu T. De novo malignant transformation of giant cell tumor of bone. Skeletal Radiol 2001; 30:104–108.

    Article  CAS  PubMed  Google Scholar 

  25. Schwartz HS, Allen GA, Chudoba I, Butler MG. Cytogenetic abnormalities in a rare case of giant cell osteogenic sarcoma. Cancer Genet Cytogenet 1992; 58:60–65.

    Article  CAS  PubMed  Google Scholar 

  26. Brien EW, Mirra JM, Kessler S, Suen M, Ho JKS, Yang WT. Benign giant cell tumor of bone with osteosarcomatous transformation (“dedifferentiated” primary malignant GCT): report of two cases. Skeletal Radiol 1997; 26:246–255.

    Article  CAS  PubMed  Google Scholar 

  27. McGrath PJ. Giant cell tumor of bone: an analysis of 52 cases. J Bone Joint Surg Br 1972; 54:216–229.

    CAS  PubMed  Google Scholar 

  28. Zhu XZ, Steiner GC. Malignant giant cell tumor of bone: malignant transformation of a benign giant cell tumor treated by surgery. Bull Hosp Jt Dis Orthop Inst 1990; 50:169–176.

    CAS  PubMed  Google Scholar 

  29. Dorfman HD, Czerniak B. Bone tumors. St Louis: Mosby, 1998:552–553.

  30. Dorfman HD, Czerniak B. Bone tumors. St Louis: Mosby, 1998:594–598.

  31. Radig K, Schneider-Stock R, Mittler U, Neumann HW, Roessner A. Genetic instability in osteoblastic tumors of the skeletal system. Path Res Pract 1998; 194:669–677.

    CAS  PubMed  Google Scholar 

  32. Bridge JA, Neff JR, Mouron BJ. Giant cell tumor of bone. Chromosomal analysis of 48 specimens and review of the literature. Cancer Genet Cytogenet 1992; 58:2–13.

    Article  CAS  PubMed  Google Scholar 

  33. Schwartz HS, Jenkins RB, Dahl RJ, Dewald GW. Cytogenetic analyses on giant-cell tumors of bone. Clin Orthop 1989; 240:250–260.

    PubMed  Google Scholar 

  34. Sara A, Ayala AG, Ei-Naggar A, Ro YJ, Raymond AK, Murray JA. Giant cell tumor of bone: a clinicopathologic and DNA flow cytometric analysis. Cancer 1990; 66:2186–2190.

    CAS  PubMed  Google Scholar 

  35. Wei G, Xiafei R, Chuanhan F. A flow cytometric study on giant cell tumor of bone. Chin Med J 1996; 109:134–137.

    PubMed  Google Scholar 

  36. Antal I, Sápi Z, Szendrôi M. The prognostic significance of DNA cytometry and proliferation index (Ki-67) in giant cell tumors of bone. Int Orthop 1999; 23:315–319.

    CAS  PubMed  Google Scholar 

  37. Murata H, Kusuzaki K, Takeshita H, et al. Cytofluorometric DNA ploidy analysis in giant cell tumor of bone: histologic and prognostic value. Cancer Lett 1999; 16:223–229.

    Article  Google Scholar 

  38. Sun D, Biesterfeld S, Adler C-P, Böcking A. Prediction of recurrence in giant cell bone tumors by DNA cytometry. Anal Quant Cytol Histol 1992; 14:341–346.

    CAS  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to H. J. Grote.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Grote, H.J., Braun, M., Kalinski, T. et al. Spontaneous malignant transformation of conventional giant cell tumor. Skeletal Radiol 33, 169–175 (2004). https://doi.org/10.1007/s00256-003-0682-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00256-003-0682-5

Keywords

  • Giant cell tumor
  • Malignant transformation
  • Prognosis
  • Bone
  • DNA image cytometry
  • Radiographs
  • MRI